Youtube
ERIS

Eris Lifesciences Ltd.

₹697.3

Score

41

Technically Neutral

Advice

Eris Lifesciences Price Change Analysis

Eris Lifesciences Key Statistics
  • P/E Ratio

    22.5

  • PEG Ratio

    1.6

  • Market Cap Cr

    9480.4

  • Price to Book Ratio

    141.1

  • EPS

    30.7

  • Dividend

    601 ()

  • Relative Strength Index

    52.27

  • Money Flow Index

    26.29

  • MACD Signal

    -7.87

  • Average True Range

    23.7

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Eris Lifesciences Synopsis

NSE-Medical-Biomed/Biotech

Eris Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1215.73 Cr. and Equity Capital is Rs. 13.59 Cr. for the Year ended 31/03/2022. Eris Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ2007PLC049867 and registration number is 049867.
  • Market Cap

    9,478.31

  • Sales

    1,215.73

  • Shares in Float

    6.39

  • No of Funds

    110

  • Yield

    0.87

  • Book Value

    4.88

  • U/D Vol Ratio

    0.8

  • LTDebt/Equity

  • Alpha

    -0.02

  • Beta

    0.64

Eris Lifesciences Ownership
Eris Lifesciences Management

Eris Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Eris Lifesciences Financials

Eris Lifesciences Technicals

EMA & SMA

CURRENT PRICE

EMA

Eris Lifesciences Resistance and Support

Eris Lifesciences Delivery and Volume

Eris Lifesciences Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Eris Lifesciences share price is

Open Demat Account